Markets
E.l.f. beauty shares rip after it receives market upgrade
(Michael M. Santiago/Getty Images)

e.l.f Beauty rips after Morgan Stanley upgrade

The market is too worried about the cosmetic company’s price hikes, the analysts say.

Matt Phillips

Cosmetics company e.l.f. Beauty jumped Monday after Morgan Stanley upgraded its rating on the stock to “over-weight” from “equal-weight” and raised its price target to $134 from $114.

Despite reporting results that more or less beat Wall Street expectations last week, e.l.f. saw its share price plunge as executives sounded less than certain that consumers would swallow the large price hikes the company is putting in place this month to offset tariff-related costs.

“With these increases just going in on August 1, we’re still reading how the consumer will respond to that,” e.l.f. CEO Mandy Fields told analysts. “It will take a couple of weeks for that to fully roll out within retail. And so that is something that we’re watching for.”

e.l.f. shares fell 9.5% the next day. But with a few days of perspective, Morgan Stanley analysts led by Dara Mohsenian have decided the market, basically, got it wrong. In a note published Monday, they wrote:

“We Believe Bear Concerns on Pricing Demand Elasticity Risk Are Overblown: ELF implemented a 14% weighted price increase on August 1... Bear worries on pricing stem from a few areas: a) low income consumers are under severe pressure in the US to begin with, so any ELF price increases could drive a large demand reaction, b) ELF has never taken such a large magnitude of price increases across its portfolio, and c) ELF has never taken pricing across its entire portfolio at once. Thus, we believe the market/consensus is currently assuming a sizeable demand elasticity response to ELF’s price increase.”

Morgan Stanley argues that’s wrong for a few reasons. One, they said, is that consumers tend to be not especially sensitive to the pricing of beauty products they use, “given the relative importance of beauty products to consumers.”

They added that e.l.f. cosmetics are already pretty cheap compared to other options, meaning there’s less opportunity for consumers to find more affordable substitutes.

The analysts also looked to the experience of consumer packaged goods companies during the 2022 inflationary period, when many companies pushed substantial price increases. The takeaway from that experience, the analysts wrote, is that sales volumes tended to react more or less similarly to small or large price increases.

In other words, while companies did lose some sales because of big price increases, sales didn’t decline anywhere near as much as prices increased. Thus companies were able to recoup any lost sales by charging more. And that’s a big part of the reason why US corporate profit surged at the time.

More Markets

See all Markets
markets

Broadcom jumps after locking down Google as a customer for future generations of TPUs

Shares of Broadcom rose more than 3% in postmarket trading on Monday after its most important customer doubled down on the custom chip specialist’s ability to produce its most valuable commodity.

In a filing, Broadcom said that it entered into a long-term agreement with Google to supply future generations of TPUs (custom AI accelerator chips) as well as a supply assurance agreement for networking and other equipment “through up to 2031.”

Bernstein analyst Stacy Rasgon indicated that Broadcom’s investor relations team told him that Google’s long-term agreement “has revenue commitments that go along with it through the timeline.”

Gemini 3 launched to rave reviews in November. The model was trained on TPUs co-developed by Broadcom and Google.

The same Monday filing showed that Broadcom, Google, and Anthropic expanded a partnership that will see the Claude developer access 3.5 gigawatts of AI compute capacity beginning in 2027, powered by the TPUs co-designed by the custom chip specialist and the search giant.

Bernstein’s Rasgon added that Broadcom’s team suggested these 3.5 gigawatts are “only part of a larger partnership over time.” He thinks Broadcom’s fiscal year 2027 guidance for AI revenues of $100 billion “is looking increasingly light” thanks to this news.

For what it’s worth, the enhanced pact with Anthropic hinges upon the firm’s ability to afford AI compute. But based on the insane trajectory of its run-rate revenue that may not be a big hurdle to clear.

“Broadcom’s expanded agreements with Google and Anthropic add rare multi-year visibility, reinforcing a $40-$50 billion AI revenue opportunity tied to Anthropic’s 3.5 gigawatt deployment starting in 2027, while building on the previously disclosed 1GW ($10 billion) starting in 2H,” wrote Bloomberg Intelligence analysts Kunjan Sobhani and Oscar Hernandez Tejada.

markets

Health insurers surge after Medicare agrees to pay 2.48% more in 2027, a bigger-than-expected boost

Health insurance stocks are surging after the Centers for Medicare & Medicaid Services said it plans to boost Medicare Advantage and Part D payments by 2.48% in calendar year 2027.

The likes of CVS, Humana, UnitedHealth, Molina Healthcare, Oscar Health, and Elevance Health are gaining in postmarket trading.

Wall Street analysts had anticipated that rates for 2027 would go up between roughly 1% and 1.5%.

These stocks had gotten crushed in late January when the Trump administration proposed relatively flat federal payment rates.

Insurance companies that provide government-sponsored plans, like Medicare Advantage, faced headwinds from higher-than-expected costs in 2025.

markets

Iran war winners Dow, LyondellBasell downgraded by Bank of America

Dow, Inc. and LyondellBasell — two petrochemicals stocks that surged as markets priced in shortages due to the closure of the Strait of Hormuz — should decline as investors focus on the long-term outlook for normalized petrochemical prices once the war resolves, Bank of America analysts wrote in a note downgrading the two stocks Monday.

BofA moved its rating on the shares from “neutral” to “underperform,” writing:

“Over time, as chemical markets normalize, we expect 1) investor focus to shiſt back to ‘normal’ or ‘sustainable’ earnings profiles and 2) the conflict to resolve without material asset rationalization, both of which likely bias shares lower over the next twelve months.”

Analysts also lowered their stance on another petrochemicals and building materials stock, Westlake, to “neutral” from “buy.”

While cutting those ratings, BofA actually raised its more near-term price targets for the shares. It upped LyondellBasell to $68 from $55, and Dow to $35 from $31.

But those price targets still imply declines of more than 10% compared to where both shares were trading late Monday morning. Both stocks are up roughly 30% since the start of the Iran war.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.